CSTL broke above its upper Bollinger Band on October 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 51 similar instances where the stock broke above the upper band. In 43 of the 51 cases the stock fell afterwards. This puts the odds of success at 84%.
The 10-day RSI Indicator for CSTL moved out of overbought territory on October 30, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 37 similar instances where the indicator moved out of overbought territory. In 28 of the 37 cases, the stock moved lower in the following days. This puts the odds of a move lower at 76%.
The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CSTL as a result. In 70 of 92 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 76%.
The Moving Average Convergence Divergence Histogram (MACD) for CSTL turned negative on November 06, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 38 similar instances when the indicator turned negative. In 27 of the 38 cases the stock turned lower in the days that followed. This puts the odds of success at 71%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CSTL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 79%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 46 of 54 cases where CSTL's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 85%.
CSTL moved above its 50-day moving average on November 12, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for CSTL crossed bullishly above the 50-day moving average on October 30, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 77%.
Following a +5.84% 3-day Advance, the price is estimated to grow further. Considering data from situations where CSTL advanced for three days, in 233 of 298 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.
The Aroon Indicator entered an Uptrend today. In 199 of 227 cases where CSTL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 88%.
The Tickeron Valuation Rating of 22 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.114) is normal, around the industry mean (67.298). P/E Ratio (-50.812) is within average values for comparable stocks, (4.239). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.473). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. P/S Ratio (2.947) is also within normal values, averaging (9.775).
The Tickeron Price Growth Rating for this company is 39 (best 1 - 100 worst), indicating steady price growth. CSTL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 83 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CSTL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 86, placing this stock worse than average.
The 10-day moving average for TCMD crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 10 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.
The Momentum Indicator moved above the 0 level on October 14, 2026. You may want to consider a long position or call options on TCMD as a result. In 74 of 98 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 76%.
TCMD moved above its 50-day moving average on October 20, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +2.03% 3-day Advance, the price is estimated to grow further. Considering data from situations where TCMD advanced for three days, in 211 of 269 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.
The Aroon Indicator entered an Uptrend today. In 201 of 234 cases where TCMD Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 86%.
The 10-day RSI Indicator for TCMD moved out of overbought territory on November 12, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 40 similar instances where the indicator moved out of overbought territory. In 23 of the 40 cases, the stock moved lower in the following days. This puts the odds of a move lower at 57%.
The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where TCMD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 75%.
TCMD broke above its upper Bollinger Band on November 03, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Price Growth Rating for this company is 40 (best 1 - 100 worst), indicating steady price growth. TCMD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 65 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 68 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.634) is normal, around the industry mean (4.142). P/E Ratio (23.881) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (0.290) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (1.458) is also within normal values, averaging (40.124).
The Tickeron PE Growth Rating for this company is 78 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TCMD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
CSTL | TCMD | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 84 | 29 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 22 Undervalued | 68 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 92 | 65 | |
PRICE GROWTH RATING 1..100 | 39 | 40 | |
P/E GROWTH RATING 1..100 | 83 | 78 | |
SEASONALITY SCORE 1..100 | 50 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CSTL's Valuation (22) in the null industry is somewhat better than the same rating for TCMD (68) in the Medical Specialties industry. This means that CSTL’s stock grew somewhat faster than TCMD’s over the last 12 months.
CSTL's Profit vs Risk Rating (100) in the null industry is in the same range as TCMD (100) in the Medical Specialties industry. This means that CSTL’s stock grew similarly to TCMD’s over the last 12 months.
TCMD's SMR Rating (65) in the Medical Specialties industry is in the same range as CSTL (92) in the null industry. This means that TCMD’s stock grew similarly to CSTL’s over the last 12 months.
CSTL's Price Growth Rating (39) in the null industry is in the same range as TCMD (40) in the Medical Specialties industry. This means that CSTL’s stock grew similarly to TCMD’s over the last 12 months.
TCMD's P/E Growth Rating (78) in the Medical Specialties industry is in the same range as CSTL (83) in the null industry. This means that TCMD’s stock grew similarly to CSTL’s over the last 12 months.
| CSTL | TCMD | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 76% | 1 day ago 57% |
| Stochastic ODDS (%) | 1 day ago 85% | 1 day ago 77% |
| Momentum ODDS (%) | 1 day ago 76% | 1 day ago 76% |
| MACD ODDS (%) | 1 day ago 71% | N/A |
| TrendWeek ODDS (%) | 1 day ago 83% | 1 day ago 83% |
| TrendMonth ODDS (%) | 1 day ago 82% | 1 day ago 85% |
| Advances ODDS (%) | 3 days ago 78% | 2 days ago 78% |
| Declines ODDS (%) | 7 days ago 79% | 7 days ago 75% |
| BollingerBands ODDS (%) | 1 day ago 84% | 1 day ago 67% |
| Aroon ODDS (%) | 1 day ago 88% | 1 day ago 86% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CSTL’s FA Score shows that 1 FA rating(s) are green while TCMD’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CSTL’s TA Score shows that 4 TA indicator(s) are bullish while TCMD’s TA Score has 5 bullish TA indicator(s).
CSTL (@Medical Specialties) experienced а -4.92% price change this week, while TCMD (@Medical/Nursing Services) price change was -0.18% for the same time period.
The average weekly price growth across all stocks in the @Medical Specialties industry was -0.30%. For the same industry, the average monthly price growth was -5.99%, and the average quarterly price growth was +36.57%.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +1.95%. For the same industry, the average monthly price growth was -5.56%, and the average quarterly price growth was -4.55%.
CSTL is expected to report earnings on Mar 04, 2027.
TCMD is expected to report earnings on Feb 23, 2027.
Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
@Medical/Nursing Services (+1.95% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
A.I.dvisor indicates that over the last year, CSTL has been loosely correlated with GH. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if CSTL jumps, then GH could also see price increases.
| Ticker / NAME | Correlation To CSTL | 1D Price Change % | ||
|---|---|---|---|---|
| CSTL | 100% | +1.50% | ||
| GH - CSTL | 54% Loosely correlated | +0.05% | ||
| TCMD - CSTL | 50% Loosely correlated | -1.14% | ||
| NEO - CSTL | 50% Loosely correlated | -1.72% | ||
| ADPT - CSTL | 49% Loosely correlated | -1.54% | ||
| NTRA - CSTL | 47% Loosely correlated | +0.98% | ||
More | ||||
A.I.dvisor indicates that over the last year, TCMD has been loosely correlated with CSTL. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if TCMD jumps, then CSTL could also see price increases.
| Ticker / NAME | Correlation To TCMD | 1D Price Change % | ||
|---|---|---|---|---|
| TCMD | 100% | -1.14% | ||
| CSTL - TCMD | 50% Loosely correlated | +1.50% | ||
| UFPT - TCMD | 46% Loosely correlated | -2.59% | ||
| AORT - TCMD | 43% Loosely correlated | -3.48% | ||
| IRMD - TCMD | 43% Loosely correlated | -1.56% | ||
| ESTA - TCMD | 38% Loosely correlated | -2.93% | ||
More | ||||